摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-5,6,7,8-tetrahydroisoquinolin-5-ol | 1372452-42-0

中文名称
——
中文别名
——
英文名称
(S)-5,6,7,8-tetrahydroisoquinolin-5-ol
英文别名
(5S)-5,6,7,8-Tetrahydro-5-isoquinolinol;(5S)-5,6,7,8-tetrahydroisoquinolin-5-ol
(S)-5,6,7,8-tetrahydroisoquinolin-5-ol化学式
CAS
1372452-42-0
化学式
C9H11NO
mdl
——
分子量
149.192
InChiKey
FZUMQCKAVKSWLQ-VIFPVBQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    299.8±25.0 °C(Predicted)
  • 密度:
    1.179±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    33.1
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    7,8-二氢-6H-异喹啉-5-酮 在 RuCl2[(2R,2’R,3S,3’S)-MeO-bisdihydrobenzooxaphosphole][(R,R)-dpen] 、 potassium tert-butylate氢气 作用下, 以 异丙醇叔丁醇 为溶剂, 反应 20.0h, 以94%的产率得到
    参考文献:
    名称:
    胺可调谐的钌催化剂,用于酮的不对称还原
    摘要:
    AbstractA series of efficient ruthenium catalysts has been developed for the asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and selectivities. The new chiral bisdihydrobenzooxaphosphole (BIBOP)/diamine‐ruthenium complexes catalyzed the enantioselective hydrogenation of substrates such as aryl and heteroaryl cyclic and alkyl ketones with substrate/catalyst (S/C) ratios of up to 100,000. The opposite sense of enantioselectivity can be obtained by proper selection of a diamine with a given chirality of the phosphine. The usefulness of the new system has been demonstrated in the asymmetric hydrogenation of a complex synthetic intermediate towards cholesteryl ester transfer protein (CETP) inhibitors at S/C 20,000 on large‐scale operation.magnified image
    DOI:
    10.1002/adsc.201300727
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL RUTHENIUM CATALYSTS AND THEIR USE FOR ASYMMETRIC REDUCTION OF KETONES<br/>[FR] NOUVEAUX CATALYSEURS AU RUTHÉNIUM ET LEUR UTILISATION POUR LA RÉDUCTION ASYMÉTRIQUE DE CÉTONES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2015002769A1
    公开(公告)日:2015-01-08
    Disclosed are novel ruthenium compounds of formula (Ia) and (Ib): wherein R1 and the moiety L ∩ L are defined herein. Also disclosed is a process for using these novel ruthenium compounds as catalysts for asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and excellent selectivities.
    揭示了一种新型钌化合物的结构式(Ia)和(Ib):其中R1和基团L ∩ L在此定义。还揭示了一种使用这些新型钌化合物作为催化剂进行不对称加氢和酮的转移加氢的方法,具有高反应性和优异选择性。
  • NOVEL RUTHENIUM CATALYSTS AND THEIR USE FOR ASYMMETRIC REDUCTION OF KETONES
    申请人:HADDAD Nizar
    公开号:US20150005500A1
    公开(公告)日:2015-01-01
    Disclosed are novel ruthenium compounds of formula (Ia) and (Ib): wherein R 1 and the moiety are defined herein. Also disclosed is a process for using these novel ruthenium compounds as catalysts for asymmetric hydrogenation and transfer hydrogenation of ketones with high reactivities and excellent selectivities.
    本发明揭示了一种新型钌化合物的化学式(Ia)和(Ib):其中R1和该基团在此定义。还揭示了一种使用这些新型钌化合物作为催化剂进行酮类的不对称氢化和转移氢化的方法,具有高反应性和优异选择性。
  • Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP2261218A2
    公开(公告)日:2010-12-15
    The present invention relates to a process for preparing a compound of formula (6a): which comprises the step of: subjecting a compound of formula (5a): and a compound of formula (4a): to a coupling reaction,
    本发明涉及一种制备式(6a)化合物的工艺: 其中包括以下步骤 将式(5a)化合物 和式 (4a) 的化合物: 进行偶联反应、
  • Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology
    作者:Andrew S. Rowan、Thomas S. Moody、Roger M. Howard、Toby J. Underwood、Iain R. Miskelly、Yanan He、Bo Wang
    DOI:10.1016/j.tetasy.2013.09.015
    日期:2013.11
    Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme (TM) carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in >= 99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield. (C) 2013 Elsevier Ltd. All rights reserved.
  • US9029540B2
    申请人:——
    公开号:US9029540B2
    公开(公告)日:2015-05-12
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-